RTX reported third-quarter 2026 sales of $25.0B, up 11%, and adjusted EPS of $2.26 on October 20, with a record $340B backlog - $164B defense and $176B commercial. Raytheon booked $52.3B in the quarter for a 6.5 book-to-bill, driven by about $23B of Tomahawk and more than $14B of AMRAAM as framework agreements converted into multi-year production contracts. RTX raised 2026 adjusted sales guidance to $97.0-97.5B and EPS to $7.65-7.75. Management framed the munitions awards as long-dated demand visibility rather than near-term revenue.